Copyright
©The Author(s) 2023.
World J Clin Cases. Jun 6, 2023; 11(16): 3765-3779
Published online Jun 6, 2023. doi: 10.12998/wjcc.v11.i16.3765
Published online Jun 6, 2023. doi: 10.12998/wjcc.v11.i16.3765
Variable | Non-Survivors | Survivors | P value | ||||
mean ± SD | Min-Max | Median (Q1-Q3) | mean ± SD | Min-max | Median (Q1-Q3) | ||
Age | 62.41 ± 14.61 | 28-82 | 66 (55.5-74.0) | 61.82 ± 14.55 | 20-92 | 64 (53.75-71.25) | 0.653 |
APACHE II | 23.93 ± 4.91 | 14-32 | 24 (20.5-28.0) | 21.08 ± 5.64 | 8-33 | 21 (17.00-25.25) | 0.012a |
SOFA score | 10.38 ± 4.71 | 2-17 | 11 (6-15) | 8.81 ± 3.73 | 2-18 | 8 (6-11) | 0.094 |
HB | 12.2 ± 11.0 | 7.2-16.7 | 10 (8.8-12.0) | 10.6 ± 2.0 | 7.1-16.9 | 10.3 (9.1-12.0) | 0.493 |
TLC | 10.0 ± 6.9 | 0.2-24.3 | 8.5 (5.4-13.8) | 13.1 ± 8.6 | 0.1-46.5 | 11.9 (6.8-16.7) | 0.101 |
PLT | 1.99 ± 0.89 | 0.25-4.08 | 1.83 (1.58-2.01) | 2.18 ± 0.95 | 0.10-5.26 | 2.10 (1.65-2.78) | 0.188 |
SBIL | 1.02 ± 0.84 | 0.28-4.70 | 0.78 (0.57-1.27) | 2.00 ± 2.90 | 0.16-18.57 | 0.8 (0.5-2.0) | 0.489 |
SALB | 2.4 ± 0.4 | 1.6-3.1 | 2.3 (2.1-2.7) | 3.1 ± 0.6 | 1.5-4.4 | 3.1 (2.7-3.5) | < 0.001a |
INR | 1.28 ± 0.29 | 0.97-2.14 | 1.18 (1.09-1.31) | 1.36 ± 0.36 | 0.95-3.83 | 1.30 (1.12-1.48) | 0.099 |
CREAT | 2.08 ± 0.95 | 0.50-4.90 | 1.80 (1.50-2.40) | 1.36 ± 1.23 | 0.20-10.50 | 1.10 (0.60-1.80) | < 0.001a |
Urea | 61.24 ± 44.91 | 9.90-229.00 | 45.60 (30.50-86.70) | 49.99 ± 31.30 | 3.30-168.90 | 41.83 (30.10-61.60) | 0.280 |
HR | 107.00 ± 15.22 | 70-128 | 112 (98-118) | 104.34 ± 15.58 | 64-156 | 106.50 (94.00-116.00) | 0.228 |
SBP | 94.66 ± 22.81 | 60-138 | 90 (74-116) | 102.71 ± 21.45 | 50-166 | 102 (90-118) | 0.065 |
DBP | 52.41 ± 14.21 | 26-87 | 50 (41-60) | 58.77 ± 15.41 | 24-97 | 60.00 (46.00-69.25) | 0.060 |
MAP | 66.24 ± 16.61 | 31-101 | 67.0 (53.0-76.5) | 73.42 ± 15.74 | 33-106 | 71 (64-85) | 0.057 |
Lactate at 0 h | 5.20 ± 1.72 | 2.10-9.40 | 5.20 (4.0-5.70) | 4.74 ± 1.69 | 2.30-9.80 | 4.40 (3.40-5.90) | 0.151 |
Lactate at 3 h | 5.54 ± 2.14 | 2.40-10.70 | 5.20 (3.80-6.70) | 3.71 ± 1.80 | 1.30-12.40 | 3.40 (2.50-4.20) | < 0.001a |
Lactate at 6 h | 6.61 ± 3.35 | 2.10-14.60 | 6.30 (3.90-8.60) | 3.21 ± 2.70 | 0.60-16.70 | 2.45 (1.90-3.30) | < 0.001a |
CRT at 0 h | 5.07 ± 2.46 | 2-12 | 5 (3-7) | 4.07 ± 2.18 | 1-9 | 3 (2-6) | 0.040a |
CRT at 3 h | 6.38 ± 2.95 | 2-13 | 6 (4-8) | 3.82 ± 2.14 | 1-10 | 3 (2-5) | < 0.001a |
CRT at 6 h | 7.10 ± 4.10 | 2-13 | 9 (3-11) | 3.63 ± 2.64 | 1-13 | 2.5 (2.0-5.0) | < 0.001a |
ScvO2 at 0 h | 68.30 ± 7.80 | 43.20-73.90 | 71.9 (70.2-72.8) | 66.20 ± 8.50 | 42.80-74.20 | 70.80 (58.90-71.90) | 0.033a |
ScvO2 at 3 h | 61.90 ± 7.10 | 45.80-73.50 | 62.8 (58.9-66.2) | 61.00 ± 6.50 | 36.80-73.70 | 61.70 (57.80-64.90) | 0.304 |
ScvO2 at 6 h | 58.10 ± 11.80 | 36.70-89.20 | 58.9 (49.7-66.2) | 60.2 ± 7.60 | 37.90-71.0 | 61.90 (56.10-65.90) | 0.299 |
P(cv-a)CO2 at 0 h | 6.50 ± 1.90 | 2.80-9.40 | 7.3 (4.9-7.9) | 5.70 ± 1.90 | 2.80-9.80 | 5.50 (4.20-7.40) | 0.036a |
P(cv-a)CO2 at 3 h | 7.00 ± 2.10 | 3.40-12.30 | 6.5 (5.6-8.6) | 5.20 ± 1.60 | 2.7-11.0 | 4.8 (4.0-6.2) | < 0.001a |
P(cv-a)CO2 at 6 h | 7.10 ± 2.50 | 2.60-10.80 | 7.4 (4.9-9.2) | 5.40 ± 4.50 | 2.60-8.70 | 4.70 (3.60-5.80) | < 0.001a |
Lactate clearance at 3 h | (-10.20 ± 35.10) | (-88.10-40.40) | (-8.6) (-37.1-24.7) | 18.80 ± 34.20 | (-183.30-58.20) | 26.80 (7.30-37.20) | < 0.001a |
Lactate clearance at 6 h | (-28.70 ± 72.80) | (-187.0-100.0) | (-46.4) (-61.5-29.9) | 29.20 ± 64.40 | (-433.80-81.30) | 44.90 (23.40-58.70) | < 0.001a |
- Citation: Kataria S, Singh O, Juneja D, Goel A, Bhide M, Yadav D. Hypoperfusion context as a predictor of 28-d all-cause mortality in septic shock patients: A comparative observational study. World J Clin Cases 2023; 11(16): 3765-3779
- URL: https://www.wjgnet.com/2307-8960/full/v11/i16/3765.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i16.3765